Lates News

On July 15th, the global leader in the field of animal health, Boehringer Ingelheim, announced its strategic partnership intention with Jilin Zhengye Biopharmaceutical Co., Ltd. The two parties will work together to promote the commercialization of innovative cattle vaccines in the mainland Chinese market. By providing innovative prevention solutions, they aim to improve the health level of dairy and beef cattle populations, and support the transformation of animal husbandry disease prevention and control and sustainable farming.